Pluri Inc. (PLUR)
$0.94-3.09%Close
SELLCRISIS · day 34
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $8M
- Beta
- 0.69
- P/E (TTM)
- -0.38
- Short % float
- 0.42%
- Days to cover
- 1.0
- SI change
- -3.0%
- 1W
- -5.05%
- 1M
- -24.19%
- vs SPY 1W
- -4.91%
- vs SPY 1M
- -26.70%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on PLUR?
- LOPJLB’s latest quantitative signal on Pluri Inc. (PLUR) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PLUR in?
- Pluri Inc. (PLUR) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Pluri Inc. (PLUR) do?
- Pluri Inc., a biotechnology company established in 2001 and headquartered in Haifa, Israel, specializes in developing innovative placenta-derived cell therapies. Its core mission is to tackle a range of inflammatory conditions, muscle injuries, and hematological disorders. The company's therapeutic pipeline centers on placental expanded (PLX) cell technology. A key candidate, PLX-PAD, is in adv…